Exact Mass: 370.9881

Exact Mass Matches: 370.9881

Found 14 metabolites which its exact mass value is equals to given mass value 370.9881, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Lornoxicam

Lornoxicam (Xefo)

C13H10ClN3O4S2 (370.9801)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AC - Oxicams C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Lornoxicam (Chlortenoxicam) is a highly active COX-1 and COX-2 inhibitor with IC50 of 5 nM and 8 nM respectively. It is a new non-steroidal anti-inflammatory compound.

   

Lornoxicam

(3E)-6-chloro-3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-2H,3H,4H-1λ⁶-thieno[2,3-e][1,2]thiazine-1,1,4-trione

C13H10ClN3O4S2 (370.9801)


Lornoxicam (chlortenoxicam) is a new nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic, anti-inflammatory and antipyretic properties. Lornoxicam differs from other oxicam compounds in its potent inhibition of prostaglandin biosynthesis, a property that explains the particularly pronounced efficacy of the drug. Lornoxicam is approved for use in Japan. Lornoxicam (Chlortenoxicam) is a highly active COX-1 and COX-2 inhibitor with IC50 of 5 nM and 8 nM respectively. It is a new non-steroidal anti-inflammatory compound.

   

Pluracidomycin C

Pluracidomycin C1

C10H13NO10S2 (370.9981)


   

Maybridge3_007186

Maybridge3_007186

C12H10FN5S4 (370.9803)


   
   

Telos

(3E)-6-chloro-3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-2H,3H,4H-1$l^{6},5,2-thieno[2,3-e][1$l^{6},2]thiazine-1,1,4-trione

C13H10ClN3O4S2 (370.9801)


Lornoxicam (Chlortenoxicam) is a highly active COX-1 and COX-2 inhibitor with IC50 of 5 nM and 8 nM respectively. It is a new non-steroidal anti-inflammatory compound.

   

Tris(pentafluoroethyl)amine

Tris(pentafluoroethyl)amine

C6F15N (370.9791)


   

1-((4-Bromo-3-(trifluoromethyl)phenyl)sulfonyl)piperidine

1-((4-Bromo-3-(trifluoromethyl)phenyl)sulfonyl)piperidine

C12H13BrF3NO2S (370.9802)


   

4-((4-(4-BROMO-1H-PYRAZOL-1-YL)PHENYL)SULFONYL)MORPHOLINE

4-((4-(4-BROMO-1H-PYRAZOL-1-YL)PHENYL)SULFONYL)MORPHOLINE

C13H14BrN3O3S (370.9939)


   

1-((3-Bromo-5-(trifluoromethyl)phenyl)sulfonyl)piperidine

1-((3-Bromo-5-(trifluoromethyl)phenyl)sulfonyl)piperidine

C12H13BrF3NO2S (370.9802)


   

1-(5-bromopyridin-2-yl)-5-methoxy-2-(trifluoromethyl)benzimidazole

1-(5-bromopyridin-2-yl)-5-methoxy-2-(trifluoromethyl)benzimidazole

C14H9BrF3N3O (370.9881)


   

5-Bromo-3-(Pyrrolidin-1-Ylsulfonyl)-1h-Indole-2-Carboxamide

5-Bromo-3-(Pyrrolidin-1-Ylsulfonyl)-1h-Indole-2-Carboxamide

C13H14BrN3O3S (370.9939)


   
   

Ferrous cysteine glycinate

Ferrous cysteine glycinate

C8H17FeN3O6S2 (370.9908)